2019 is now really starting in China, with the beginning of the Year of the Pig. Everybody in the China pharma market is focusing on how the new central purchasing pilot will be deployed in the coming months. At first glance it looks familiar, with convergence with known international practices: strengthening of bidding rules, phasing […]
Life Science & Health
Healthcare in China will benefit from Important progress made in 2018 in terms of the registration and approval policy for innovative drugs.
The Life Sciences and Healthcare practice of Cornerstone International Group is gearing up for increased activity in India. Within only a few months of its formation, the team in India has added three senior level executive search resources effective January 1, 2017. India’s pharmaceutical market is the world’s third largest in volume and the largest […]
(Or how to be successful in times of uncertainty and constant changes) 2016 will be a year of global as well as local changes in the pharmaceutical industry. Mexico will have a marginal GDP growth and limited government spending in the sector. Industry leaders reflect on their experience and share with us the most relevant […]
China today is gearing up for an explosion in the development of private healthcare that is expected to exceed US $100 billion by 2030.
Taipei, TW, October 28, 2015 — Healthcare CEOs in Taiwan expect to benefit from reforms and growth of healthcare IT in 2016, according to a recent forum organized by Cornerstone International Group here. The meeting of key healthcare leaders launched a new Life Science practice group for Cornerstone International Group in Asia. The organization is […]
Shanghai, CH, October 20, 2015 – Cornerstone International Group has established a new Health and Life Science Practice Group serving its seven member locations in China and Taiwan. The team leader is Dominic Yim, a seasoned executive with 20 plus years as corporate executive in the medical device industry, the last five years in executive […]